NCT06229366 2025-12-22
ACCEL
Eli Lilly and Company
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT05067140 2025-03-17
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
Novartis
Phase 1/2 Active not recruiting
NCT02266745 2024-04-05
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
Promontory Therapeutics Inc.
Phase 2 Active not recruiting
NCT01464216 2022-06-21
FuncProst
Oslo University Hospital
Active not recruiting